CBAY — CymaBay Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for CymaBay Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	191	146	187	135	394
Net Total Accounts Receivable
Net Total Receivables	0.687	0.277	—	—	—
Prepaid Expenses
Total Current Assets	203	152	191	138	404
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.64	2.03	1.43	0.87	5.72
Long Term Investments
Other Long Term Assets
Total Assets	206	154	202	142	435
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	17.6	9.86	18.4	15.4	36.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	19.4	11.1	69.4	106	142
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	186	143	133	36.2	292
Total Liabilities & Shareholders' Equity	206	154	202	142	435
Total Common Shares Outstanding